Korea Class I Express Registration: 30-Day Pathway Explained
MFDS Class I medical devices use a notification pathway that can clear in 30 days — but only when documentation is correctly prepared. Here's what foreign manufacturers need.

What Makes Class I Different
The Class I pathway differs from Class II–IV in three meaningful ways:
| Aspect | Class I (Notification) | Class II–IV (Registration) |
|---|---|---|
| Pathway name | 신고 (Notification) | 허가 (Registration) |
| KGMP required | No | Yes |
| MFDS review | Administrative completeness | Full technical review |
| Typical clearance | 30–60 days | 60+ days (II), 6–12 months (III, IV) |
| Clinical evidence | Not required | Required (most cases) |
| Official fees | ₩4M+ ($3K+) | |
| Foreign manufacturer KLH | Required | Required |
When Class I Notification Is the Right Call
Class I notification fits well when:
- Device is unambiguously Class I per Korean Medical Device Classification Code
- Manufacturing site does not require KGMP for other Korean market products
- Time-to-market is critical
- Budget is constrained
It is the wrong call when:
- Classification is borderline (Class I/II edge case) — MFDS may reclassify mid-review
- Device is part of a product line where higher-class siblings need KGMP anyway
- Distributor requires the prestige signal of full registration (rare, but happens)
The 30-Day Pathway: What Actually Happens
Day 0: Notification Filing
Foreign manufacturer (via KLH) files notification through MFDS electronic portal.
Required documents:
- Device classification declaration
- Device description and intended use (Korean)
- Manufacturing site information
- KLH information and agreement
- Korean labeling and IFU (mockup acceptable)
- Reference standards (Korean Medical Device Standard codes)
Not required for Class I:
- KGMP certificate
- Clinical evaluation report
- Risk management file (summary acceptable)
- Performance testing reports (basic declaration acceptable)
Days 1–7: Administrative Review
MFDS reviews for completeness. Common reasons for rejection at this stage:
- Korean labeling missing MFDS-mandated elements
- Classification declaration ambiguous
- KLH agreement incomplete
Days 7–30: Substantive Review
MFDS evaluates classification correctness and basic conformity. For straightforward Class I:
- ~70% complete review within 30 days
- ~25% extend to 45–60 days (additional clarification)
- ~5% reclassified to Class II (requires withdrawal and refiling)
Day 30–60: KMD Number Issuance
Once cleared, KLH receives Korean Medical Device (KMD) number. Product can be legally imported and sold.
The 5 Mistakes That Slow Class I
Mistake 1: Over-Documenting
Foreign manufacturers accustomed to FDA 510(k) or EU MDR submit 200+ page dossiers for Class I notification. MFDS reviewers flag this as "documentation incommensurate with risk class" and may reclassify.
Fix: Submit 30–60 page notification. Reference KGMP / ISO 13485 conformity by certificate number rather than full documentation.
Mistake 2: Ambiguous Classification
Class I devices that have "monitoring" or "diagnostic" claims edge into Class II. MFDS reviewers err toward higher classification when intended use is unclear.
Fix: Use unambiguous Class I intended-use language. Avoid "monitoring," "diagnostic," "therapeutic decision-support" phrasings for Class I devices.
Mistake 3: Distributor as KLH (Default Choice)
Many manufacturers default to their Korean distributor as KLH. This creates commercial leverage issues post-approval.
Fix: Consider independent KLH service even for Class I to preserve future flexibility.
Mistake 4: Korean Labeling as Afterthought
Korean labels missing MFDS-mandated warnings cause notification holds.
Fix: Build Korean labels from MFDS Notice 2022-110 requirements during preparation, not after.
Mistake 5: Skipping Korean Medical Device Standard Mapping
Class I notifications still require referencing applicable Korean Medical Device Standards (식약처 고시) for materials, performance, and safety.
Fix: Identify relevant Korean Medical Device Standard codes during preparation. Reference them in notification.
Cost Comparison
| Item | Class I Notification | Class II Registration |
|---|---|---|
| MFDS official fees | ~₩300K ($220) | ₩4M–₩8M ($3K–$6K) |
| Documentation preparation | $3K–$8K | $15K–$40K |
| KGMP (if required) | N/A | $15K–$45K |
| KLH setup | $2K–$5K | $2K–$5K |
| Translation | $2K–$5K | $5K–$15K |
| Total | $7K–$18K | $40K–$110K |
| Timeline | 30–60 days | 4–9 months |
Foreign manufacturers entering Korea with Class I products often achieve revenue 6+ months earlier than Class II competitors at 10–20% the regulatory cost.
Frequently Asked Questions
Q: Can we self-classify our device as Class I?
A: Yes, but MFDS reserves the right to reclassify during review. For borderline devices, pre-submission classification consultation with MFDS is recommended. Misclassification adds 60–90 days to clearance.
Q: Do we still need a Korea License Holder for Class I?
A: Yes. All foreign manufacturers — regardless of device class — require a KLH (Korea License Holder) to file notifications and hold the resulting KMD number.
Q: Does Class I exempt us from post-market obligations?
A: No. Class I devices still require adverse event reporting, change notifications, and KLH-maintained vigilance. Obligations are lighter than Class II–IV but not absent.
Q: Can we upgrade from Class I to higher class later?
A: Yes, but requires new registration (not modification of existing notification). If you plan to add higher-risk variants, consider Class II registration from the start.
Q: How long does Leanabl typically take to clear a Class I notification?
A: 30–45 days for clean cases with prepared documentation. Total project (preparation + clearance) typically 6–10 weeks.
How Leanabl Helps
- Korea Class I Express Registration — accelerated Class I pathway
- KLH Service — independent Korea License Holder
- Regulatory Pathway Strategy — Class I vs Class II decision support
Contact Leanabl for Class I scoping.
Last updated: 2026-05-15.
Have a regulatory question?
Talk to a Korea regulatory specialist about your device, your timeline, or your next submission.
Talk to a specialist

